Published in Osteoporos Int on January 04, 2006
Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med (2013) 2.06
Low bone mineral density and fracture burden in postmenopausal women. CMAJ (2007) 1.81
A multidisciplinary, multifactorial intervention program reduces postoperative falls and injuries after femoral neck fracture. Osteoporos Int (2006) 1.69
Baseline age and time to major fracture in younger postmenopausal women. Menopause (2015) 1.49
Assessment of Bone Mineral Density in Male Patients with Chronic Obstructive Pulmonary Disease by DXA and Quantitative Computed Tomography. Int J Endocrinol (2016) 1.39
Hip fractures in Italy: 2000-2005 extension study. Osteoporos Int (2009) 1.36
Trabecular structure quantified with the MRI-based virtual bone biopsy in postmenopausal women contributes to vertebral deformity burden independent of areal vertebral BMD. J Bone Miner Res (2008) 1.24
Association between change in BMD and fragility fracture in women and men. J Bone Miner Res (2009) 1.19
Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res (2010) 1.18
The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther (2010) 1.17
Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2008) 1.15
Prevention of osteoporosis-related fractures among postmenopausal women and older men. CMAJ (2009) 1.12
Epidemiology of fragility fractures in Italy. Clin Cases Miner Bone Metab (2011) 1.10
Updated incidence rates of fragility fractures in Italy: extension study 2002-2008. Clin Cases Miner Bone Metab (2011) 1.08
Computational biomechanics of the distal tibia from high-resolution MR and micro-CT images. Bone (2010) 1.04
Prevalence of osteoporosis in patients requiring spine surgery: incidence and significance of osteoporosis in spine disease. Osteoporos Int (2007) 1.03
Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures. Osteoporos Int (2011) 1.02
Racial and ethnic differences in physical activity and bone density: National Health and Nutrition Examination Survey, 2007-2008. Prev Chronic Dis (2013) 0.95
Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med (2007) 0.94
Age trends in proximal femur geometry in men: variation by race and ethnicity. Osteoporos Int (2007) 0.94
The TARGET project in Tuscany: the first disease management model of a regional project for the prevention of hip re-fractures in the elderly. Clin Cases Miner Bone Metab (2010) 0.93
Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos (2009) 0.90
Progressive load training for the quadriceps muscle associated with proprioception exercises for the prevention of falls in postmenopausal women with osteoporosis: a randomized controlled trial. Osteoporos Int (2009) 0.89
The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol (2008) 0.89
Teriparatide in the management of osteoporosis. Clin Interv Aging (2007) 0.89
Feasibility of FRAX for Prediction of Osteoporotic Vertebral Fractures in Korea. Asian Spine J (2012) 0.87
Prediction of incident hip fracture by femoral neck bone mineral density and neck-shaft angle: a 5-year longitudinal study in post-menopausal females. Br J Radiol (2011) 0.86
Factors predicting osteoporosis treatment initiation in a regionally based cohort. Osteoporos Int (2008) 0.85
Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS). Calcif Tissue Int (2012) 0.85
Pharmacological treatment of hip fractured patients in Italy: a simulation based on Tuscany regional database for the TARGET project. Clin Cases Miner Bone Metab (2010) 0.85
Antifracture drugs consumption in Tuscany Region before the Target Project: a valuable model for the analysis of administrative database. Clin Cases Miner Bone Metab (2012) 0.85
The management of osteoporosis in breast cancer survivors. Maturitas (2012) 0.84
Exercise prescription after fragility fracture in older adults: a scoping review. Osteoporos Int (2010) 0.84
Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women. Osteoporos Int (2011) 0.82
Assessment of fracture risk in women with breast cancer using current vs emerging guidelines. Br J Cancer (2010) 0.82
Breast cancer survivorship issues. Hematol Oncol Clin North Am (2013) 0.82
Determination of an applicable FRAX model in Korean women. J Korean Med Sci (2010) 0.81
The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications. J Osteoporos (2011) 0.79
Development and validation of a tool for identifying women with low bone mineral density and low-impact fractures: the São Paulo Osteoporosis Risk Index (SAPORI). Osteoporos Int (2011) 0.79
Pharmaco-economic issues in the treatment of severe osteoporosis. Clin Cases Miner Bone Metab (2010) 0.79
Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture. Osteoporos Int (2007) 0.79
Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health (2016) 0.78
Evaluation of postural balance in postmenopausal women and its relationship with bone mineral density--a cross sectional study. BMC Musculoskelet Disord (2012) 0.77
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. Clin Interv Aging (2011) 0.77
Ultrasonic assessment of the radius in vitro. Ultrasound Med Biol (2008) 0.77
Predicting trabecular bone elastic properties from measures of bone volume fraction and fabric on the basis of micromagnetic resonance images. Magn Reson Med (2011) 0.76
Cancer Treatment-Induced Bone Loss in women with breast cancer. Bonekey Rep (2015) 0.76
First meeting on bone quality, Abbaye des Vaux de Cernay, France, 15-16 June 2006: Bone architecture. Osteoporos Int (2007) 0.75
Towards the in vivo prediction of fragility fractures with Raman spectroscopy. J Raman Spectrosc (2015) 0.75
Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence. J Cachexia Sarcopenia Muscle (2012) 0.75
The use of computed tomography attenuation to evaluate osteoporosis following acute fractures of the thoracic and lumbar vertebra. Geriatr Orthop Surg Rehabil (2014) 0.75
Breast cancer and osteoporosis - management of cancer treatment-induced bone loss in postmenopausal women with breast cancer. Breast Care (Basel) (2014) 0.75
Usefulness of Fracture Risk Assessment Tool Using Lumbar Bone Mineral Density in Prediction of Osteoporotic Vertebral Fracture. J Korean Neurosurg Soc (2015) 0.75
Osteoprotective effect of hormone therapy on bone microarchitecture before impaired bone mineral density in ovariectomized rats. J Turk Ger Gynecol Assoc (2012) 0.75
Radiographic texture analysis of densitometric calcaneal images: relationship to clinical characteristics and to bone fragility. J Bone Miner Res (2010) 0.75
Feasibility of assessing bone matrix and mineral properties in vivo by combined solid-state 1H and 31P MRI. PLoS One (2017) 0.75
Practical use of bone scan in patients with an osteoporotic vertebral compression fracture. J Korean Med Sci (2015) 0.75
OSTEOPOROSIS DIAGNOSIS AND TREATMENT. Rev Bras Ortop (2015) 0.75
Non-participation in systematic screening for osteoporosis-the ROSE trial. Osteoporos Int (2017) 0.75
Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
Diagnosis of osteoporosis and assessment of fracture risk. Lancet (2002) 7.38
Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA (1990) 6.25
Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int (1997) 5.82
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74
Age and bone mass as predictors of fracture in a prospective study. J Clin Invest (1988) 4.46
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93
Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (1993) 3.55
Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res (2004) 3.37
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int (2001) 3.23
Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int (2000) 2.99
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc (2000) 2.80
Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int (2000) 2.52
Hip fracture in women without osteoporosis. J Clin Endocrinol Metab (2005) 2.35
Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med (1989) 2.30
Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res (1995) 2.12
Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int (2002) 2.01
Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. Ann Intern Med (1991) 1.94
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (1999) 1.92
A model of lifetime osteoporosis impact. Arch Intern Med (1991) 1.91
Axial and appendicular bone density predict fractures in older women. J Bone Miner Res (1992) 1.80
Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res (2004) 1.79
Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. Osteoporos Int (1994) 1.60
Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res (2002) 1.58
Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. J Clin Endocrinol Metab (1996) 1.53
Discordance in patient classification using T-scores. J Clin Densitom (1999) 1.46
Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Introduction. Osteoporos Int (1998) 1.46
Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol (1999) 1.38
Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. Am J Med (1995) 1.35
Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res (1992) 1.34
Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo Study. J Am Geriatr Soc (1995) 1.20
Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporos Int (1996) 1.15
Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate. Osteoporos Int (1998) 1.14
Prevention of osteoporotic hip fracture: global versus high-risk strategies. Osteoporos Int (1998) 1.00
Mineral density of bone in the forearm in premenopausal women with fractured wrists. BMJ (1988) 0.99
Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. J Bone Miner Res (1995) 0.93
The prevalence of osteoporosis. J Bone Miner Res (1997) 0.92
Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporos Int (2001) 0.90
Design of NORA, the National Osteoporosis Risk Assessment Program: a longitudinal US registry of postmenopausal women. Osteoporos Int (1998) 0.89
Bone mineral density assessment: comparison of dual-energy X-ray absorptiometry measurements at the calcaneus, spine, and hip. J Clin Densitom (2002) 0.84
Osteoporosis and Colles' fractures in the elderly. J Hand Surg Br (1987) 0.83
Should age influence the choice of quantitative bone assessment technique in elderly women? The EPIDOS study. Osteoporos Int (2004) 0.79
Discordance in lumbar spine T-scores and nonstandardization of standard deviations. J Clin Densitom (2003) 0.78
The effects of standardization and reference values on patient classification for spine and femur dual-energy X-ray absorptiometry. Osteoporos Int (1997) 0.78
Peripheral or central densitometry: does it matter which technique we use? J Clin Densitom (2001) 0.77
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Central obesity and increased risk of dementia more than three decades later. Neurology (2008) 6.03
The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis (1971) 4.88
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med (1990) 4.10
Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol (1978) 3.90
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
A classification of marginal tissue recession. Int J Periodontics Restorative Dent (1985) 3.62
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation (1987) 3.49
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology (2004) 3.47
Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) (1971) 3.40
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med (1993) 3.23
Burden of migraine in the United States: disability and economic costs. Arch Intern Med (1999) 3.05
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab (2010) 2.99
The prevalence of peripheral arterial disease in a defined population. Circulation (1985) 2.88
Latent and chronic infections imported from Southeast Asia. JAMA (1978) 2.78
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet (1985) 2.62
The epidemiology of head injury: a prospective study of an entire community-San Diego County, California, 1978. Am J Epidemiol (1981) 2.58
Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA (1983) 2.57
Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol (1994) 2.50
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
Exercise patterns in a population of older adults. Am J Prev Med (1989) 2.28
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med (1986) 2.18
Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation (1997) 2.17
Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study. Am J Epidemiol (1982) 2.15
Cognitive and functional status of the oldest old. J Am Geriatr Soc (1996) 2.14
Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study. Am J Epidemiol (1985) 2.12
Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation (2001) 2.12
Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol (1997) 2.06
A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol (1990) 2.05
Dietary calcium and risk of hip fracture: 14-year prospective population study. Lancet (1988) 2.05
Eosinophilic prostatitis and prostatic specific antigen. Br J Urol (1992) 2.04
The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med (1989) 2.03
Indirect cost of ischemic heart disease to employers. Am J Manag Care (2001) 2.03
Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res (1997) 2.03
Payment for labour in monkeys. Nature (2000) 2.00
A prospective study of alcohol consumption and bone mineral density. BMJ (1993) 1.99
Depressive symptoms in overweight and obese older adults: a test of the "jolly fat" hypothesis. J Psychosom Res (1996) 1.97
Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med (1998) 1.96
Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev (1985) 1.95
Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med (1987) 1.95
GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care (1996) 1.90
Physical exercise, sports, and lung function in smoking versus nonsmoking adolescents. Eur Respir J (2002) 1.89
Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab (2000) 1.88
Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II. Mol Ther (2005) 1.88
Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med (1988) 1.88
Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med (2001) 1.87
Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol (1998) 1.86
Health problems in teenage daily smokers versus nonsmokers, Norway, 1995-1997: the Nord-Trøndelag Health Study. Am J Epidemiol (2000) 1.85
Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int (1993) 1.84
Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol (1993) 1.81
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med (1999) 1.81
Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells. Mol Genet Metab (2012) 1.79
The postwar hospitalization experience of U.S. veterans of the Persian Gulf War. N Engl J Med (1996) 1.77
Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. Am J Hum Genet (2007) 1.76
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76
The effect of response bias on the odds ratio. Am J Epidemiol (1981) 1.73
Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation (1984) 1.73
Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol (1998) 1.70
Ischemic heart disease risk factors after age 50. J Chronic Dis (1984) 1.69
PALS db: Putative Alternative Splicing database. Nucleic Acids Res (2002) 1.68
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis (2005) 1.66
Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol (1983) 1.66
Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int (2007) 1.61
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab (2015) 1.61
Diabetes and pancreatic carcinoma. Diabete Metab (1994) 1.59
A prospective study of Type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med (2004) 1.58
Estrogen replacement therapy and the risk of venous thrombosis. Am J Med (1992) 1.58
Management of prolonged pregnancy: induction of labor versus antepartum fetal testing. Am J Obstet Gynecol (1987) 1.56
Chemoprophylaxis of malaria for travelers. Ann Intern Med (1974) 1.55
The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation (1985) 1.52
Pregnancy and lactation as determinants of bone mineral density in postmenopausal women. Am J Epidemiol (1992) 1.52
Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab (2000) 1.51
Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med (2001) 1.51
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med (2013) 1.51
A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int (1998) 1.50
Long-term postmenopausal hormone use, obesity, and fat distribution in older women. JAMA (1996) 1.48
The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol (1983) 1.46
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. Osteoporos Int (2011) 1.45
Alcohol consumption and blood pressure. The lipid research clinics prevalence study. Hypertension (1982) 1.44
Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis (2005) 1.44
The association between blood pressure, age, and dietary sodium and potassium: a population study. Circulation (1988) 1.43
Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis. Am Fam Physician (2000) 1.43
Coronal positioning of existing gingiva: short term results in the treatment of shallow marginal tissue recession. J Periodontol (1989) 1.42
25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology (2009) 1.40
Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes. Clin Pharmacol Ther (2008) 1.40
Tolerability of risedronate in postmenopausal women intolerant of alendronate. Aging (Milano) (2001) 1.40
Current indications for hormone replacement therapy. Natl Med J India (1999) 1.39
Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene (2006) 1.39
"Evidence-based" or "logic-based" medicine? Osteoporos Int (2010) 1.38
Fasting plasma glucose, uric acid, and triglycerides as predictors of the ratio of total cholesterol to HDL-C. Am J Clin Pathol (1984) 1.37
Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae. Neuroscience (1984) 1.37
Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care (2000) 1.34